These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 15592417)

  • 1. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
    Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
    Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
    J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
    Weichold FF; Mueller S; Kortsik C; Hitzler WE; Wulf MJ; Hone DM; Sadoff JC; Maeurer MJ
    Genes Immun; 2007 Jun; 8(4):334-43. PubMed ID: 17429413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
    Geldmacher C; Currier JR; Herrmann E; Haule A; Kuta E; McCutchan F; Njovu L; Geis S; Hoffmann O; Maboko L; Williamson C; Birx D; Meyerhans A; Cox J; Hoelscher M
    J Virol; 2007 Mar; 81(5):2440-8. PubMed ID: 17182686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
    Scott-Algara D; Buseyne F; Blanche S; Rouzioux C; Jouanne C; Romagné F; Rivière Y
    J Infect Dis; 2001 Jun; 183(11):1565-73. PubMed ID: 11343205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.
    Kloverpris HN; Stryhn A; Harndahl M; van der Stok M; Payne RP; Matthews PC; Chen F; Riddell L; Walker BD; Ndung'u T; Buus S; Goulder P
    J Virol; 2012 Jan; 86(2):919-29. PubMed ID: 22090105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians.
    Ferrari G; Currier JR; Harris ME; Finkelstein S; de Oliveira A; Barkhan D; Cox JH; Zeira M; Weinhold KJ; Reinsmoen N; McCutchan F; Birx DL; Osmanov S; Maayan S
    Hum Immunol; 2004 Jun; 65(6):648-59. PubMed ID: 15219385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control.
    Xie J; Lu W; Samri A; Costagliola D; Schnuriger A; da Silva BC; Blanc C; Larsen M; Theodorou I; Rouzioux C; Autran B;
    AIDS; 2010 Sep; 24(15):2323-9. PubMed ID: 20802296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
    Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV evolution: CTL escape mutation and reversion after transmission.
    Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
    Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
    Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B
    J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
    Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
    Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601.
    Satoh M; Takamiya Y; Oka S; Tokunaga K; Takiguchi M
    Vaccine; 2005 May; 23(29):3783-90. PubMed ID: 15893615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.